This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Magdalena Thurin: Innovator in Immunotherapy
Introduction
Magdalena Thurin is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of immunotherapy, particularly through her work on monoclonal antibodies. Her innovative approach has the potential to enhance diagnostic and therapeutic methods in medicine.
Latest Patents
Thurin holds a patent for "Monoclonal antibodies against glycolipid antigens, methods of producing." This invention focuses on in vitro and in vivo immunodiagnosis and immunotherapy using monoclonal antibodies that are reactive with difucosyl blood group antigens Y-6 and B-7-2. This patent represents a crucial advancement in the development of targeted therapies.
Career Highlights
Magdalena Thurin is affiliated with The Wistar Institute, where she conducts her research. Her work has been instrumental in advancing the understanding of immune responses and developing new therapeutic strategies. With 1 patent to her name, she continues to push the boundaries of scientific innovation.
Collaborations
Thurin has collaborated with notable colleagues, including Zenon Steplewski and Hilary Koprowski. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Magdalena Thurin's contributions to immunotherapy through her patented inventions highlight her role as a leading innovator in the scientific community. Her work not only advances medical research but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile